Coherus Oncology, Inc 10-Q for FY2024 Q2
Coherus Oncology, Inc. (CHRS)
10-Q
2024-08-08
For: 2024-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Coherus Oncology, Inc filed this 10-Q on August 8, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $64.98M
- up 10.7% from $58.72M a year earlier
- Net loss
- $12.92M
- compared with a net loss of $42.87M a year earlier
- Diluted EPS
- -$0.11
- compared with -$0.49 a year earlier